173 related articles for article (PubMed ID: 23981338)
21. Enhancing effect of N-octyl-O-sulfate chitosan on etoposide absorption.
Mo R; Xiao Y; Sun M; Zhang C; Ping Q
Int J Pharm; 2011 May; 409(1-2):38-45. PubMed ID: 21356302
[TBL] [Abstract][Full Text] [Related]
22. In vitro predictability of drug-drug interaction likelihood of P-glycoprotein-mediated efflux of dabigatran etexilate based on [I]2/IC50 threshold.
Kishimoto W; Ishiguro N; Ludwig-Schwellinger E; Ebner T; Schaefer O
Drug Metab Dispos; 2014 Feb; 42(2):257-63. PubMed ID: 24212378
[TBL] [Abstract][Full Text] [Related]
23. PEPT1- and OAT1/3-mediated drug-drug interactions between bestatin and cefixime in vivo and in vitro in rats, and in vitro in human.
Wang L; Wang C; Liu Q; Meng Q; Huo X; Sun P; Yang X; Sun H; Zhen Y; Peng J; Ma X; Liu K
Eur J Pharm Sci; 2014 Oct; 63():77-86. PubMed ID: 25016073
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone.
Yumoto R; Murakami T; Sanemasa M; Nasu R; Nagai J; Takano M
Drug Metab Dispos; 2001 Feb; 29(2):145-51. PubMed ID: 11159804
[TBL] [Abstract][Full Text] [Related]
25. Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans.
Oswald S; Haenisch S; Fricke C; Sudhop T; Remmler C; Giessmann T; Jedlitschky G; Adam U; Dazert E; Warzok R; Wacke W; Cascorbi I; Kroemer HK; Weitschies W; von Bergmann K; Siegmund W
Clin Pharmacol Ther; 2006 Mar; 79(3):206-17. PubMed ID: 16513445
[TBL] [Abstract][Full Text] [Related]
26. In situ kinetic modelling of intestinal efflux in rats: functional characterization of segmental differences and correlation with in vitro results.
González-Alvarez I; Fernández-Teruel C; Casabó-Alós VG; Garrigues TM; Polli JE; Ruiz-García A; Bermejo M
Biopharm Drug Dispos; 2007 Jul; 28(5):229-39. PubMed ID: 17410527
[TBL] [Abstract][Full Text] [Related]
27. Menadione serves as a substrate for P-glycoprotein: implication in chemosensitizing activity.
Oh SJ; Han HK; Kang KW; Lee YJ; Lee MY
Arch Pharm Res; 2013 Apr; 36(4):509-16. PubMed ID: 23435914
[TBL] [Abstract][Full Text] [Related]
28. Impact of P-glycoprotein on clopidogrel absorption.
Taubert D; von Beckerath N; Grimberg G; Lazar A; Jung N; Goeser T; Kastrati A; Schömig A; Schömig E
Clin Pharmacol Ther; 2006 Nov; 80(5):486-501. PubMed ID: 17112805
[TBL] [Abstract][Full Text] [Related]
29. Periplocymarin is a potential natural compound for drug development: highly permeable with absence of P-glycoprotein efflux and cytochrome P450 inhibitions.
Martey ON; He X; Xing H; Deng F; Feng S; Li C; Shi X
Biopharm Drug Dispos; 2014 May; 35(4):195-206. PubMed ID: 24424534
[TBL] [Abstract][Full Text] [Related]
30. Modulation of the cellular accumulation and intracellular activity of daptomycin towards phagocytized Staphylococcus aureus by the P-glycoprotein (MDR1) efflux transporter in human THP-1 macrophages and madin-darby canine kidney cells.
Lemaire S; Van Bambeke F; Mingeot-Leclercq MP; Tulkens PM
Antimicrob Agents Chemother; 2007 Aug; 51(8):2748-57. PubMed ID: 17548493
[TBL] [Abstract][Full Text] [Related]
31. Study on in situ and in vivo absorption kinetics of phenytoin by modulating P-glycoprotein with verapamil in rats.
Neerati P; Ganji D; Bedada SK
Eur J Pharm Sci; 2011 Sep; 44(1-2):27-31. PubMed ID: 21640186
[TBL] [Abstract][Full Text] [Related]
32. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells.
Sun LR; Li X; Cheng YN; Yuan HY; Chen MH; Tang W; Ward SG; Qu XJ
Biomed Pharmacother; 2009 Mar; 63(3):202-8. PubMed ID: 18818047
[TBL] [Abstract][Full Text] [Related]
33. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.
Zhu HJ; Wang JS; Markowitz JS; Donovan JL; Gibson BB; Gefroh HA; Devane CL
J Pharmacol Exp Ther; 2006 May; 317(2):850-7. PubMed ID: 16439618
[TBL] [Abstract][Full Text] [Related]
34. Effect of P-glycoprotein on the rat intestinal permeability and metabolism of the BDDCS class 1 drug verapamil.
Estudante M; Maya M; Morais JG; Soveral G; Benet LZ
Mol Pharm; 2013 Nov; 10(11):4038-45. PubMed ID: 24044638
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
[TBL] [Abstract][Full Text] [Related]
36. Induction of apoptosis by A3 adenosine receptor agonist N-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide in human leukaemia cells: a possible involvement of intracellular mechanism.
Mlejnek P; Dolezel P
Acta Physiol (Oxf); 2010 Jun; 199(2):171-9. PubMed ID: 20121715
[TBL] [Abstract][Full Text] [Related]
37. [Effect of P-glycoprotein on the absorption of buagafuran in rat intestinal lumen].
Li E; Li Y
Yao Xue Xue Bao; 2008 Apr; 43(4):361-5. PubMed ID: 18664196
[TBL] [Abstract][Full Text] [Related]
38. Existence of a p-glycoprotein drug efflux pump in cultured rabbit conjunctival epithelial cells.
Saha P; Yang JJ; Lee VH
Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1221-6. PubMed ID: 9620082
[TBL] [Abstract][Full Text] [Related]
39. Sensitization and apoptosis augmentation of K562/ADM cells by anti-multidrug resistance gene peptide nucleic acid and antisense oligodeoxyribonucleotide.
Wei HL; Wu YJ; Jing T; Bai DC; Ma LF
Acta Pharmacol Sin; 2003 Aug; 24(8):805-11. PubMed ID: 12904281
[TBL] [Abstract][Full Text] [Related]
40. A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier.
Hendrikse NH; de Vries EG; Eriks-Fluks L; van der Graaf WT; Hospers GA; Willemsen AT; Vaalburg W; Franssen EJ
Cancer Res; 1999 May; 59(10):2411-6. PubMed ID: 10344751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
